Amgen Inc. v. Teva Pharmaceuticals USA, Inc. et al > Summary
Court Case Number 1:17-cv-01809
Filing Date Dec 15, 2017
Termination Date Feb 13, 2018
Court Delaware District Court
Status Dismissed - Settled
JudgesGregory M. Sleet
Plaintiff
Defendant
Plaintiff Attorneys
8Amgen
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Amgen
Attorney Name: Maryellen Noreika
Morris Nichols Arsht & Tunnell
Amgen
Attorney Name: John D. Murnane
Venable
Amgen
Attorney Name: Joshua I. Rothman
Venable
Amgen
Attorney Name: Alicia A. Russo
Venable
Amgen
Attorney Name: Wendy A. Whiteford
Amgen
Amgen
Attorney Name: Lois Marie Kwasigroch
Amgen
Amgen
Attorney Name: Eric M. Agovino
Amgen
Defendant Attorneys
Teva Pharmaceuticals
Attorney Name: David M. Fry
Shaw Keller LLP
Cause
35:271 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
09375405 | Rapid dissolution formulation of a calcium receptor-active compound | Jun 28, 2016 |
07829595 | Rapid dissolution formulation of a calcium receptor-active compound | Nov 9, 2010 |
06313146 | Calcium receptor-active molecules | Nov 6, 2001 |
06211244 | Calcium receptor-active compounds | Apr 3, 2001 |
06031003 | Calcium receptor-active molecules | Feb 29, 2000 |
06011068 | Calcium receptor-active molecules | Jan 4, 2000 |